A selective policy in follow-up for bowel cancer.
Ross
P J
PJ
Cunningham
D
D
D000359:Aftercare / Q000379:methods*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010166:Palliative Care / Q000379:methods*; D016019:Survival Analysis; D013997:Time Factors
D000970:Antineoplastic Agents